Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation

Once thought to be exclusively a storage hub for glucose, glycogen is now known to be essential in a range of physiological processes and pathological conditions. Glycogen lies at the nexus of diverse processes that promote malignancy, including proliferation, migration, invasion, and chemoresistanc...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 10; p. 592455
Main Authors Khan, Tashbib, Sullivan, Mitchell A., Gunter, Jennifer H., Kryza, Thomas, Lyons, Nicholas, He, Yaowu, Hooper, John D.
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 30.10.2020
Subjects
cancer metabolism
cancer therapy
chemoresistance
glycogen
immunometabolism
metabolic reprogramming
Oncology
Online AccessGet full text

Cover

Abstract Once thought to be exclusively a storage hub for glucose, glycogen is now known to be essential in a range of physiological processes and pathological conditions. Glycogen lies at the nexus of diverse processes that promote malignancy, including proliferation, migration, invasion, and chemoresistance of cancer cells. It is also implicated in processes associated with the tumor microenvironment such as immune cell effector function and crosstalk with cancer-associated fibroblasts to promote metastasis. The enzymes of glycogen metabolism are dysregulated in a wide variety of malignancies, including cancers of the kidney, ovary, lung, bladder, liver, blood, and breast. Understanding and targeting glycogen metabolism in cancer presents a promising but under-explored therapeutic avenue. In this review, we summarize the current literature on the role of glycogen in cancer progression and discuss its potential as a therapeutic target for cancer treatment.
AbstractList Once thought to be exclusively a storage hub for glucose, glycogen is now known to be essential in a range of physiological processes and pathological conditions. Glycogen lies at the nexus of diverse processes that promote malignancy, including proliferation, migration, invasion, and chemoresistance of cancer cells. It is also implicated in processes associated with the tumor microenvironment such as immune cell effector function and crosstalk with cancer-associated fibroblasts to promote metastasis. The enzymes of glycogen metabolism are dysregulated in a wide variety of malignancies, including cancers of the kidney, ovary, lung, bladder, liver, blood, and breast. Understanding and targeting glycogen metabolism in cancer presents a promising but under-explored therapeutic avenue. In this review, we summarize the current literature on the role of glycogen in cancer progression and discuss its potential as a therapeutic target for cancer treatment.
Author He, Yaowu
Kryza, Thomas
Hooper, John D.
Sullivan, Mitchell A.
Lyons, Nicholas
Khan, Tashbib
Gunter, Jennifer H.
AuthorAffiliation 2 Faculty of Health, Australian Prostate Cancer Research Centre-Queensland, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology , Woolloongabba, QLD , Australia
1 Mater Research Institute—The University of Queensland, Translational Research Institute , Woolloongabba, QLD , Australia
AuthorAffiliation_xml – name: 1 Mater Research Institute—The University of Queensland, Translational Research Institute , Woolloongabba, QLD , Australia
– name: 2 Faculty of Health, Australian Prostate Cancer Research Centre-Queensland, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology , Woolloongabba, QLD , Australia
Author_xml – sequence: 1
  givenname: Tashbib
  surname: Khan
  fullname: Khan, Tashbib
– sequence: 2
  givenname: Mitchell A.
  surname: Sullivan
  fullname: Sullivan, Mitchell A.
– sequence: 3
  givenname: Jennifer H.
  surname: Gunter
  fullname: Gunter, Jennifer H.
– sequence: 4
  givenname: Thomas
  surname: Kryza
  fullname: Kryza, Thomas
– sequence: 5
  givenname: Nicholas
  surname: Lyons
  fullname: Lyons, Nicholas
– sequence: 6
  givenname: Yaowu
  surname: He
  fullname: He, Yaowu
– sequence: 7
  givenname: John D.
  surname: Hooper
  fullname: Hooper, John D.
BookMark eNpVkU1rGzEQhkVISVI39x517MWuvnfVQyGYNA2kFIoDvYlZ7WirsJZcaR3Iv886DqWZywySeN5Bz3tymnJCQj5ytpKytZ9DTn4lmGArbYXS-oRcCCHV0ir5-_S_-Zxc1vrA5jKacSbPyLmUQqi2bS6I-4WPscYppoHejE8-D5hoTHQNyWP5Qq_oOqe6i36f95VC6ukGyoATdCPS63RoheZAf8AYhwRpopsCqYZctjDFnD6QdwHGipevfUHuv11v1t-Xdz9vbtdXd0uvpJ2WyHuPYEyHAXvNg22DgJ4pZtFz1gehmfWeGa6k8UKj7IwywQaGXmlhrVyQ2yO3z_DgdiVuoTy5DNG9HOQyOChT9CM6jSg0903HLFfBajDWGBFE2zNvrdUz6-uRtdt3W5wXS1OB8Q307U2Kf9yQH11jTKN5MwM-vQJK_rvHOrltrB7HERLO3-iEMlLPSbOiBWHHp77kWguGfzGcuYNmd9DsDprdUbN8Bm9HnSs
CitedBy_id crossref_primary_10_3389_fonc_2021_783194
crossref_primary_10_1016_j_phymed_2022_154631
crossref_primary_10_1016_j_semcancer_2022_03_023
crossref_primary_10_12677_ACM_2023_13122616
crossref_primary_10_3389_fonc_2022_979154
crossref_primary_10_3389_fcell_2021_667311
crossref_primary_10_3389_fphar_2021_723066
crossref_primary_10_1016_j_bspc_2023_105169
crossref_primary_10_1038_s41419_022_05005_2
crossref_primary_10_3389_fmolb_2021_673315
crossref_primary_10_1038_s41467_023_38437_1
crossref_primary_10_1096_fj_202300783RR
crossref_primary_10_1016_j_bbamcr_2023_119585
crossref_primary_10_3389_fendo_2023_1265698
crossref_primary_10_1155_2022_5346091
crossref_primary_10_1016_j_jbc_2022_102177
crossref_primary_10_3390_cancers13112731
crossref_primary_10_3390_ijms24076133
crossref_primary_10_1016_j_ijbiomac_2024_129432
crossref_primary_10_3390_nu14173636
Cites_doi 10.2353/ajpath.2010.100105
10.1073/pnas.0803090105
10.3892/or.15.1.187
10.18632/oncotarget.5228
10.1002/emmm.201100193
10.1371/journal.pone.0009644
10.1038/nature25167
10.1002/path.5037
10.1111/j.1600-0854.2009.00969.x
10.3390/cancers12040869
10.1038/s41577-019-0140-9
10.1158/1541-7786.MCR-14-0314
10.3389/fncel.2019.00082
10.1038/sj.bjc.6605437
10.1007/s00109-015-1377-9
10.1016/j.jgg.2015.03.003
10.1158/0008-5472.CAN-14-2268
10.1200/jco.2014.32.15_suppl.e16509
10.1158/1078-0432.CCR-15-1706
10.3389/fonc.2012.00018
10.1038/s41574-020-0329-9
10.3892/mmr.2018.9022
10.1038/nrclinonc.2016.217
10.3390/cancers11071036
10.1016/j.ygyno.2007.03.041
10.1038/leu.2015.46
10.1038/nchembio744
10.1186/1471-2490-5-6
10.1016/j.bbrc.2012.05.147
10.3389/fphys.2011.00112
10.18632/oncotarget.24676
10.3389/fonc.2020.00005
10.1007/s10719-007-9075-7
10.1038/nrd3504
10.1016/j.ccell.2019.04.002
10.18632/oncotarget.17445
10.1097/IGC.0000000000001050
10.1002/JLB.3A0819-207RR
10.3892/or.2014.3268
10.3389/fonc.2017.00278
10.1038/sj.cr.7310078
10.1074/jbc.M004485200
10.1371/journal.pone.0220973
10.1016/j.celrep.2018.03.075
10.3390/cells9030715
10.3389/fncel.2019.00374
10.1016/1357-2725(95)00110-7
10.5483/BMBRep.2019.52.1.291
10.1038/nrc1187
10.1016/j.immuni.2015.09.001
10.3390/jcm8020246
10.1126/scitranslmed.aaa1009
10.3389/fcell.2018.00090
10.7150/ijbs.33278
10.1074/mcp.RA118.000586
10.1016/j.cmet.2017.05.014
10.1016/j.bbacli.2016.02.001
10.1016/j.cmet.2018.08.007
10.1002/pros.21172
10.1002/acn3.51009
10.1111/j.1474-9726.2008.00436.x
10.1126/science.aaw5473
10.1016/j.ebiom.2019.07.067
10.1038/s41416-019-0717-x
10.1002/prp2.389
10.1016/j.trecan.2019.05.003
10.1111/j.1349-7006.2008.00747.x
10.1371/journal.pone.0061537
10.1158/1535-7163.MCT-17-1299
10.1007/978-1-4939-7598-3_4
10.1016/j.tranon.2019.10.015
10.1016/j.bcp.2014.09.001
10.1038/jcbfm.2014.33
10.1042/BJ20111416
10.1007/s11912-013-0346-0
10.1016/j.yexcr.2019.05.017
10.1517/13543776.2016.1131268
10.1158/0008-5472.CAN-18-2738
10.1007/s00280-013-2358-8
10.1093/glycob/cwx005
10.1371/journal.pone.0064570
10.1038/s41556-018-0249-2
10.1158/1078-0432.CCR-040020
10.1016/j.cmet.2017.08.012
10.1007/s00280-012-2045-1
10.1093/jnci/dju062
10.1073/pnas.1603244113
10.1016/j.ccell.2019.03.007
10.1158/0008-5472.CAN-13-2768
10.1158/1078-0432.CCR-15-2240
10.4103/ctm.ctm_22_18
10.1038/s41568-019-0216-7
10.3389/fonc.2019.00322
10.1016/j.jim.2018.04.006
10.1158/1541-7786.MCR-14-0106-T
10.1038/nature12222
10.1074/jbc.R117.802843
10.3802/jgo.2016.27.e31
10.1093/annonc/mdx104
10.1155/2017/4629495
10.1038/onc.2009.470
10.1111/pin.12954
10.1016/S0006-291X(03)01542-0
10.1016/j.chembiol.2017.08.028
10.18632/oncotarget.7998
10.1038/sj.bjc.6602243
10.1016/j.cell.2020.03.008
10.1113/jphysiol.2011.203570
10.1038/s41556-017-0002-2
10.1038/s41586-019-1715-0
10.2174/1566524018666181109121849
10.1038/s41467-020-15636-8
10.1200/JCO.2017.35.15_suppl.5556
10.3892/ol.2017.7412
10.1016/j.cmet.2012.10.017
10.1016/j.cmet.2019.08.014
10.3389/fonc.2018.00237
10.1093/jjco/hyu221
10.1002/slct.201901293
10.1038/s41418-018-0075-x
10.1038/nrurol.2015.111
10.1083/jcb.201807127
10.1016/j.biopha.2019.109449
10.1016/j.ebiom.2019.11.017
10.1016/j.cmet.2016.10.016
10.1097/MPA.0b013e318236f022
10.1016/j.neuroscience.2014.06.024
10.1038/nature17038
10.1038/s41392-019-0095-0
ContentType Journal Article
Copyright Copyright © 2020 Khan, Sullivan, Gunter, Kryza, Lyons, He and Hooper. 2020 Khan, Sullivan, Gunter, Kryza, Lyons, He and Hooper
Copyright_xml – notice: Copyright © 2020 Khan, Sullivan, Gunter, Kryza, Lyons, He and Hooper. 2020 Khan, Sullivan, Gunter, Kryza, Lyons, He and Hooper
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fonc.2020.592455
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-943X
EndPage 592455
ExternalDocumentID oai_doaj_org_article_5ee251c7b0914f95a69662f28d0c9995
10_3389_fonc_2020_592455
GrantInformation_xml – fundername: Mater Foundation
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EJD
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
7X8
5PM
ID FETCH-LOGICAL-c439t-e1dcea66befed51f98f2ad0409ec10df2509cc061436c25e3b646f9f0ec452993
IEDL.DBID RPM
ISSN 2234-943X
IngestDate Tue Dec 17 15:26:10 EST 2024
Tue Sep 17 21:00:58 EDT 2024
Fri Oct 25 00:55:30 EDT 2024
Thu Sep 26 16:24:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-e1dcea66befed51f98f2ad0409ec10df2509cc061436c25e3b646f9f0ec452993
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Cancer Metabolism, a section of the journal Frontiers in Oncology
Reviewed by: Domenica Scumaci, Magna Græcia University of Catanzaro, Italy; Angela Ostuni, University of Basilicata, Italy
Edited by: Fatima Baltazar, University of Minho, Portugal
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667517/
PMID 33224887
PQID 2463599522
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_5ee251c7b0914f95a69662f28d0c9995
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7667517
proquest_miscellaneous_2463599522
crossref_primary_10_3389_fonc_2020_592455
PublicationCentury 2000
PublicationDate 2020-10-30
PublicationDateYYYYMMDD 2020-10-30
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-30
  day: 30
PublicationDecade 2020
PublicationTitle Frontiers in oncology
PublicationYear 2020
Publisher Frontiers Media S.A
Publisher_xml – sequence: 0
  name: Frontiers Media S.A
– name: Frontiers Media S.A
References Oishi (B107) 2014; 32
Walz (B113) 2017; 23
Mandai (B37) 2015; 6
Skurat (B88) 2017; 27
Vlachostergios (B109) 2017; 28
Cao (B111) 2006; 16
Sasano (B106) 2015; 13
Saez (B29) 2014; 34
Rousset (B11) 1981; 41
Possik (B90) 2018; 1732
Calì (B5) 2019; 13
Curtis (B74) 2019; 29
Rosenzweig (B75) 2018; 6
Beloueche-Babari (B67) 2020; 122
Thwe (B56) 2019; 106
Ma (B60) 2018; 20
Pescador (B33) 2010; 5
Khan (B97) 2020; 12
Kaley (B104) 2020; 7
Prats (B2) 2018; 293
Stein (B96) 2010; 70
Cheng (B39) 2012; 4
Roach (B1) 2012; 441
Zois (B10) 2014; 92
Yamaguchi (B105) 2010; 29
Guin (B19) 2016; 22
Biswas (B54) 2015; 43
Barot (B121) 2019; 381
Zhang (B129) 2009
Remo (B24) 2019; 11
Lee (B36) 2007; 106
Hassannia (B128) 2019; 35
Adeva-Andany (B3) 2016; 5
Momcilovic (B95) 2019; 575
Kwon (B44) 2019; 52
Oikonomakos (B124) 2000; 275
Abbadi (B101) 2014; 12
Ricketts (B42) 2018; 23
Ma (B123) 2012; 41
Thwe (B57) 2017; 26
Xu (B62) 2019; 9
Schulz (B30) 2020; 219
Milanovic (B49) 2018; 553
Mancinelli (B86) 2017; 2017
Gomez-Roman (B41) 2016; 7
Louzao (B89) 2008; 25
Kawazoe (B112) 2012; 423
Qiu (B130) 2018; 25
Chen (B76) 2015; 75
Jensen (B4) 2011; 2
Komatsu (B53) 2006; 15
Murray (B66) 2005; 1
Shapiro (B125) 2004; 10
Zois (B9) 2016; 94
Ashcroft (B6) 2017; 26
Takehara (B84) 2014; 32
Hoxhaj (B13) 2020; 20
Lee (B122) 2004; 91
Zi (B114) 2018; 15
Song (B14) 2019; 79
Ritterson Lew (B21) 2015; 12
Dauer (B8) 2019; 5
Elgendy (B116) 2019; 35
Vander Heiden (B65) 2011; 10
Itamochi (B82) 2008; 99
Favaro (B12) 2012; 16
Pelletier (B32) 2012; 2
Hopkins (B85) 2020; 16
Sullivan (B7) 2019; 47
Seo (B45) 2008; 7
Le Bourgeois (B61) 2018; 8
Agarwal (B40) 2009; 10
Lee (B47) 2019; 21
Ma (B59) 2020; 11
Makhov (B81) 2018; 17
Guo (B108) 2015; 42
Witney (B92) 2014; 74
Donnier-Marechal (B120) 2016; 26
Ji (B26) 2018; 244
Thwe (B91) 2018; 458
Li (B73) 2018; 17
Yang (B18) 2019; 15
Buckanovich (B115) 2017; 35
Luengo (B70) 2017; 24
Zhou (B16) 2019; 120
Bhanot (B17) 2015; 29
Czech-Damal (B31) 2014; 275
Curtis (B58) 2020; 9
O'Sullivan (B55) 2019; 19
Yoshii (B94) 2013; 8
Sarfstein (B117) 2013; 8
Matsui (B78) 2011; 589
Cheng (B52) 2019; 4
Mantovani (B64) 2016; 24
Zhang (B72) 2018; 18
Ma (B87) 2020; 10
Venneti (B93) 2015; 7
Yamashita (B80) 2015; 45
Creighton (B43) 2013; 499
Yang (B131) 2016; 113
Richmond (B20) 2018; 9
Lengyel (B79) 2010; 177
Massagué (B69) 2016; 529
Pezzuto (B35) 2018; 18
Sun (B51) 2019; 30
Ralser (B99) 2008; 105
van der Mijn (B22) 2020; 13
Colwell (B98) 1996; 28
Abdulfatah (B25) 2017; 27
Tan (B38) 2019; 50
Ailanen (B118) 2018; 6
Ruscetti (B50) 2020; 181
Schnier (B127) 2003; 309
Faubert (B68) 2020; 368
Semenza (B34) 2003; 3
Kato (B28) 2020; 70
Zeng (B46) 2018; 4
Yu (B15) 2017; 8
Zhou (B23) 2019; 8
Duran (B77) 2019; 13
Guin (B119) 2014; 106
Mantovani (B63) 2017; 14
Mabuchi (B83) 2016; 27
Raez (B102) 2013; 71
Guo (B103) 2019; 4
Schosserer (B48) 2017; 7
Altemus (B71) 2019; 14
Glasspool (B27) 2013; 15
Bilim (B110) 2009; 101
Schnier (B126) 2005; 5
Philips (B100) 2014; 73
References_xml – volume: 177
  start-page: 1053
  year: 2010
  ident: B79
  article-title: Ovarian cancer development and metastasis
  publication-title: Am J Pathol.
  doi: 10.2353/ajpath.2010.100105
  contributor:
    fullname: Lengyel
– volume: 105
  start-page: 17807
  year: 2008
  ident: B99
  article-title: A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth
  publication-title: Proc Natl Acad Sci U S A.
  doi: 10.1073/pnas.0803090105
  contributor:
    fullname: Ralser
– volume: 15
  start-page: 187
  year: 2006
  ident: B53
  article-title: SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells
  publication-title: Oncol Rep.
  doi: 10.3892/or.15.1.187
  contributor:
    fullname: Komatsu
– volume: 6
  start-page: 30704
  year: 2015
  ident: B37
  article-title: Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.5228
  contributor:
    fullname: Mandai
– volume: 4
  start-page: 125
  year: 2012
  ident: B39
  article-title: Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress
  publication-title: EMBO Mol Med.
  doi: 10.1002/emmm.201100193
  contributor:
    fullname: Cheng
– volume: 5
  start-page: e9644
  year: 2010
  ident: B33
  article-title: Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0009644
  contributor:
    fullname: Pescador
– volume: 553
  start-page: 96
  year: 2018
  ident: B49
  article-title: Senescence-associated reprogramming promotes cancer stemness
  publication-title: Nature.
  doi: 10.1038/nature25167
  contributor:
    fullname: Milanovic
– volume: 244
  start-page: 550
  year: 2018
  ident: B26
  article-title: Clear cell carcinomas of the ovary and kidney: clarity through genomics
  publication-title: J Pathol.
  doi: 10.1002/path.5037
  contributor:
    fullname: Ji
– volume: 10
  start-page: 1561
  year: 2009
  ident: B40
  article-title: The emerging role of the RAB25 small GTPase in cancer
  publication-title: Traffic.
  doi: 10.1111/j.1600-0854.2009.00969.x
  contributor:
    fullname: Agarwal
– volume: 12
  start-page: 869
  year: 2020
  ident: B97
  article-title: Disruption of glycogen utilization markedly improves the efficacy of carboplatin against preclinical models of clear cell ovarian carcinoma
  publication-title: Cancers.
  doi: 10.3390/cancers12040869
  contributor:
    fullname: Khan
– volume: 19
  start-page: 324
  year: 2019
  ident: B55
  article-title: Metabolic interventions in the immune response to cancer
  publication-title: Nat Rev Immunol.
  doi: 10.1038/s41577-019-0140-9
  contributor:
    fullname: O'Sullivan
– volume: 13
  start-page: 795
  year: 2015
  ident: B106
  article-title: Preclinical efficacy for AKT targeting in clear cell carcinoma of the ovary
  publication-title: Mol Cancer Res.
  doi: 10.1158/1541-7786.MCR-14-0314
  contributor:
    fullname: Sasano
– volume: 13
  start-page: 82
  year: 2019
  ident: B5
  article-title: The strategic location of glycogen and lactate: from body energy reserve to brain plasticity
  publication-title: Front Cell Neurosci.
  doi: 10.3389/fncel.2019.00082
  contributor:
    fullname: Calì
– volume: 101
  start-page: 2005
  year: 2009
  ident: B110
  article-title: Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
  publication-title: Br J Cancer.
  doi: 10.1038/sj.bjc.6605437
  contributor:
    fullname: Bilim
– volume: 94
  start-page: 137
  year: 2016
  ident: B9
  article-title: Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy
  publication-title: J Mol Med (Berl).
  doi: 10.1007/s00109-015-1377-9
  contributor:
    fullname: Zois
– volume: 42
  start-page: 343
  year: 2015
  ident: B108
  article-title: The PI3K/AKT pathway and renal cell carcinoma
  publication-title: J Genet Genomics.
  doi: 10.1016/j.jgg.2015.03.003
  contributor:
    fullname: Guo
– volume: 75
  start-page: 554
  year: 2015
  ident: B76
  article-title: Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-14-2268
  contributor:
    fullname: Chen
– volume: 32
  start-page: e16509
  year: 2014
  ident: B84
  article-title: SUV max of FDG-PET/CT as a prognostic factor in ovarian clear cell adenocarcinoma
  publication-title: J Clin Oncol.
  doi: 10.1200/jco.2014.32.15_suppl.e16509
  contributor:
    fullname: Takehara
– volume: 22
  start-page: 1274
  year: 2016
  ident: B19
  article-title: Loss of glycogen debranching enzyme AGL drives bladder tumor growth via induction of hyaluronic acid synthesis
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-1706
  contributor:
    fullname: Guin
– volume: 2
  start-page: 18
  year: 2012
  ident: B32
  article-title: Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2012.00018
  contributor:
    fullname: Pelletier
– volume: 16
  start-page: 276
  year: 2020
  ident: B85
  article-title: Insulin-PI3K signalling: an evolutionarily insulated metabolic driver of cancer
  publication-title: Nat Rev Endocrinol.
  doi: 10.1038/s41574-020-0329-9
  contributor:
    fullname: Hopkins
– volume: 18
  start-page: 715
  year: 2018
  ident: B72
  article-title: PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines
  publication-title: Mol Med Rep.
  doi: 10.3892/mmr.2018.9022
  contributor:
    fullname: Zhang
– volume: 14
  start-page: 399
  year: 2017
  ident: B63
  article-title: Tumour-associated macrophages as treatment targets in oncology
  publication-title: Nat Rev Clin Oncol.
  doi: 10.1038/nrclinonc.2016.217
  contributor:
    fullname: Mantovani
– volume: 11
  start-page: 1036
  year: 2019
  ident: B24
  article-title: Morphology and molecular features of rare colorectal carcinoma histotypes
  publication-title: Cancers.
  doi: 10.3390/cancers11071036
  contributor:
    fullname: Remo
– volume: 106
  start-page: 311
  year: 2007
  ident: B36
  article-title: Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma
  publication-title: Gynecol Oncol.
  doi: 10.1016/j.ygyno.2007.03.041
  contributor:
    fullname: Lee
– volume: 29
  start-page: 1555
  year: 2015
  ident: B17
  article-title: Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells
  publication-title: Leukemia.
  doi: 10.1038/leu.2015.46
  contributor:
    fullname: Bhanot
– volume: 1
  start-page: 371
  year: 2005
  ident: B66
  article-title: Monocarboxylate transporter MCT1 is a target for immunosuppression
  publication-title: Nat Chem Biol.
  doi: 10.1038/nchembio744
  contributor:
    fullname: Murray
– volume: 5
  start-page: 6
  year: 2005
  ident: B126
  article-title: Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer
  publication-title: BMC Urol.
  doi: 10.1186/1471-2490-5-6
  contributor:
    fullname: Schnier
– volume: 423
  start-page: 490
  year: 2012
  ident: B112
  article-title: GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC)
  publication-title: Biochem Biophys Res Commun.
  doi: 10.1016/j.bbrc.2012.05.147
  contributor:
    fullname: Kawazoe
– volume: 2
  start-page: 112
  year: 2011
  ident: B4
  article-title: The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise
  publication-title: Front Physiol.
  doi: 10.3389/fphys.2011.00112
  contributor:
    fullname: Jensen
– volume: 9
  start-page: 16718
  year: 2018
  ident: B20
  article-title: Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.24676
  contributor:
    fullname: Richmond
– volume: 10
  start-page: 5
  year: 2020
  ident: B87
  article-title: Metabolic symbiosis in chemoresistance: refocusing the role of aerobic glycolysis
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2020.00005
  contributor:
    fullname: Ma
– volume: 25
  start-page: 503
  year: 2008
  ident: B89
  article-title: “Fluorescent glycogen” formation with sensibility for in vivo and in vitro detection
  publication-title: Glycoconj J.
  doi: 10.1007/s10719-007-9075-7
  contributor:
    fullname: Louzao
– volume: 10
  start-page: 671
  year: 2011
  ident: B65
  article-title: Targeting cancer metabolism: a therapeutic window opens
  publication-title: Nat Rev Drug Disc.
  doi: 10.1038/nrd3504
  contributor:
    fullname: Vander Heiden
– start-page: 332
  volume-title: Science
  year: 2009
  ident: B129
  article-title: RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis
  contributor:
    fullname: Zhang
– volume: 35
  start-page: 830
  year: 2019
  ident: B128
  article-title: Targeting ferroptosis to iron out cancer
  publication-title: Cancer Cell.
  doi: 10.1016/j.ccell.2019.04.002
  contributor:
    fullname: Hassannia
– volume: 8
  start-page: 43356
  year: 2017
  ident: B15
  article-title: The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.17445
  contributor:
    fullname: Yu
– volume: 27
  start-page: 1714
  year: 2017
  ident: B25
  article-title: Clear cell carcinoma of the endometrium: evaluation of prognostic parameters in a multi-institutional cohort of 165 cases
  publication-title: Int J Gynecol Cancer.
  doi: 10.1097/IGC.0000000000001050
  contributor:
    fullname: Abdulfatah
– volume: 106
  start-page: 1325
  year: 2019
  ident: B56
  article-title: Syk-dependent glycolytic reprogramming in dendritic cells regulates IL-1β production to β-glucan ligands in a TLR-independent manner
  publication-title: J Leukoc Biol.
  doi: 10.1002/JLB.3A0819-207RR
  contributor:
    fullname: Thwe
– volume: 32
  start-page: 553
  year: 2014
  ident: B107
  article-title: The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma
  publication-title: Oncol Rep.
  doi: 10.3892/or.2014.3268
  contributor:
    fullname: Oishi
– volume: 7
  start-page: 278
  year: 2017
  ident: B48
  article-title: The dual role of cellular senescence in developing tumors and their response to cancer therapy
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2017.00278
  contributor:
    fullname: Schosserer
– volume: 16
  start-page: 671
  year: 2006
  ident: B111
  article-title: Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
  publication-title: Cell Res.
  doi: 10.1038/sj.cr.7310078
  contributor:
    fullname: Cao
– volume: 275
  start-page: 34566
  year: 2000
  ident: B124
  article-title: Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M004485200
  contributor:
    fullname: Oikonomakos
– volume: 14
  start-page: e0220973
  year: 2019
  ident: B71
  article-title: Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0220973
  contributor:
    fullname: Altemus
– volume: 23
  start-page: 313
  year: 2018
  ident: B42
  article-title: The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2018.03.075
  contributor:
    fullname: Ricketts
– volume: 9
  start-page: 715
  year: 2020
  ident: B58
  article-title: Glycogen metabolism supports early glycolytic reprogramming and activation in dendritic cells in response to both TLR and Syk-dependent CLR agonists
  publication-title: Cells.
  doi: 10.3390/cells9030715
  contributor:
    fullname: Curtis
– volume: 13
  start-page: 374
  year: 2019
  ident: B77
  article-title: Lack of neuronal glycogen impairs memory formation and learning-dependent synaptic plasticity in mice
  publication-title: Front Cell Neurosci.
  doi: 10.3389/fncel.2019.00374
  contributor:
    fullname: Duran
– volume: 28
  start-page: 115
  year: 1996
  ident: B98
  article-title: Incorporation of 2-deoxy-D-glucose into glycogen. Implications for measurement of tissue-specific glucose uptake and utilisation
  publication-title: Int J Biochem Cell Biol.
  doi: 10.1016/1357-2725(95)00110-7
  contributor:
    fullname: Colwell
– volume: 52
  start-page: 5
  year: 2019
  ident: B44
  article-title: Metabolic features and regulation in cell senescence
  publication-title: BMB Rep.
  doi: 10.5483/BMBRep.2019.52.1.291
  contributor:
    fullname: Kwon
– volume: 3
  start-page: 721
  year: 2003
  ident: B34
  article-title: Targeting HIF-1 for cancer therapy
  publication-title: Nat Rev Cancer.
  doi: 10.1038/nrc1187
  contributor:
    fullname: Semenza
– volume: 43
  start-page: 435
  year: 2015
  ident: B54
  article-title: Metabolic reprogramming of immune cells in cancer progression
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2015.09.001
  contributor:
    fullname: Biswas
– volume: 8
  start-page: 246
  year: 2019
  ident: B23
  article-title: Clinical features, survival and prognostic factors of glycogen-rich clear cell carcinoma (GRCC) of the breast in the U.S. Population
  publication-title: J Clin Med.
  doi: 10.3390/jcm8020246
  contributor:
    fullname: Zhou
– volume: 7
  start-page: 274ra17
  year: 2015
  ident: B93
  article-title: Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aaa1009
  contributor:
    fullname: Venneti
– volume: 6
  start-page: 90
  year: 2018
  ident: B75
  article-title: Beyond the Warburg effect: how do cancer cells regulate one-carbon metabolism?
  publication-title: Front Cell Dev Biol.
  doi: 10.3389/fcell.2018.00090
  contributor:
    fullname: Rosenzweig
– volume: 15
  start-page: 2596
  year: 2019
  ident: B18
  article-title: Phosphorylase kinase β represents a novel prognostic biomarker and inhibits malignant phenotypes of liver cancer cell
  publication-title: Int J Biol Sci.
  doi: 10.7150/ijbs.33278
  contributor:
    fullname: Yang
– volume: 17
  start-page: 607
  year: 2018
  ident: B73
  article-title: Multiomics integration reveals the landscape of prometastasis metabolism in hepatocellular carcinoma
  publication-title: Mol Cell Proteomics.
  doi: 10.1074/mcp.RA118.000586
  contributor:
    fullname: Li
– volume: 26
  start-page: 17
  year: 2017
  ident: B6
  article-title: Is type 2 diabetes a glycogen storage disease of pancreatic β cells?
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2017.05.014
  contributor:
    fullname: Ashcroft
– volume: 5
  start-page: 85
  year: 2016
  ident: B3
  article-title: Glycogen metabolism in humans
  publication-title: BBA Clin.
  doi: 10.1016/j.bbacli.2016.02.001
  contributor:
    fullname: Adeva-Andany
– volume: 29
  start-page: 141
  year: 2019
  ident: B74
  article-title: Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2018.08.007
  contributor:
    fullname: Curtis
– volume: 70
  start-page: 1388
  year: 2010
  ident: B96
  article-title: Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies
  publication-title: Prostate.
  doi: 10.1002/pros.21172
  contributor:
    fullname: Stein
– volume: 7
  start-page: 429
  year: 2020
  ident: B104
  article-title: Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma
  publication-title: Ann Clin Transl Neurol.
  doi: 10.1002/acn3.51009
  contributor:
    fullname: Kaley
– volume: 7
  start-page: 894
  year: 2008
  ident: B45
  article-title: Enhanced glycogenesis is involved in cellular senescence via GSK3/GS modulation
  publication-title: Aging Cell.
  doi: 10.1111/j.1474-9726.2008.00436.x
  contributor:
    fullname: Seo
– volume: 41
  start-page: 1165
  year: 1981
  ident: B11
  article-title: Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins
  publication-title: Cancer Res.
  contributor:
    fullname: Rousset
– volume: 368
  start-page: eaaw5473
  year: 2020
  ident: B68
  article-title: Metabolic reprogramming and cancer progression
  publication-title: Science.
  doi: 10.1126/science.aaw5473
  contributor:
    fullname: Faubert
– volume: 47
  start-page: 590
  year: 2019
  ident: B7
  article-title: Glucose and glycogen in the diabetic kidney: heroes or villains?
  publication-title: EBioMedicine.
  doi: 10.1016/j.ebiom.2019.07.067
  contributor:
    fullname: Sullivan
– volume: 122
  start-page: 895
  year: 2020
  ident: B67
  article-title: Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration
  publication-title: Br J Cancer.
  doi: 10.1038/s41416-019-0717-x
  contributor:
    fullname: Beloueche-Babari
– volume: 6
  start-page: e00389
  year: 2018
  ident: B118
  article-title: Metformin normalizes the structural changes in glycogen preceding prediabetes in mice overexpressing neuropeptide Y in noradrenergic neurons
  publication-title: Pharmacol Res Perspect.
  doi: 10.1002/prp2.389
  contributor:
    fullname: Ailanen
– volume: 5
  start-page: 396
  year: 2019
  ident: B8
  article-title: New roles for glycogen in tumor progression
  publication-title: Trends Cancer.
  doi: 10.1016/j.trecan.2019.05.003
  contributor:
    fullname: Dauer
– volume: 99
  start-page: 653
  year: 2008
  ident: B82
  article-title: Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2008.00747.x
  contributor:
    fullname: Itamochi
– volume: 8
  start-page: e61537
  year: 2013
  ident: B117
  article-title: Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0061537
  contributor:
    fullname: Sarfstein
– volume: 17
  start-page: 1355
  year: 2018
  ident: B81
  article-title: Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies
  publication-title: Mol Cancer Ther.
  doi: 10.1158/1535-7163.MCT-17-1299
  contributor:
    fullname: Makhov
– volume: 1732
  start-page: 57
  year: 2018
  ident: B90
  article-title: Biochemical measurement of glycogen: method to investigate the AMPK-glycogen relationship
  publication-title: Methods Mol Biol.
  doi: 10.1007/978-1-4939-7598-3_4
  contributor:
    fullname: Possik
– volume: 13
  start-page: 177
  year: 2020
  ident: B22
  article-title: Combined metabolomics and genome-wide transcriptomics analyses show multiple HIF1α-induced changes in lipid metabolism in early stage clear cell renal cell carcinoma
  publication-title: Transl Oncol.
  doi: 10.1016/j.tranon.2019.10.015
  contributor:
    fullname: van der Mijn
– volume: 92
  start-page: 3
  year: 2014
  ident: B10
  article-title: Glycogen metabolism in cancer
  publication-title: Biochem Pharmacol.
  doi: 10.1016/j.bcp.2014.09.001
  contributor:
    fullname: Zois
– volume: 34
  start-page: 945
  year: 2014
  ident: B29
  article-title: Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia
  publication-title: J Cereb Blood Flow Metab.
  doi: 10.1038/jcbfm.2014.33
  contributor:
    fullname: Saez
– volume: 441
  start-page: 763
  year: 2012
  ident: B1
  article-title: Glycogen and its metabolism: some new developments and old themes
  publication-title: Biochem J.
  doi: 10.1042/BJ20111416
  contributor:
    fullname: Roach
– volume: 15
  start-page: 566
  year: 2013
  ident: B27
  article-title: Clear cell carcinoma of ovary and uterus
  publication-title: Curr Oncol Rep.
  doi: 10.1007/s11912-013-0346-0
  contributor:
    fullname: Glasspool
– volume: 381
  start-page: 288
  year: 2019
  ident: B121
  article-title: Inhibition of glycogen catabolism induces intrinsic apoptosis and augments multikinase inhibitors in hepatocellular carcinoma cells
  publication-title: Exp Cell Res.
  doi: 10.1016/j.yexcr.2019.05.017
  contributor:
    fullname: Barot
– volume: 26
  start-page: 199
  year: 2016
  ident: B120
  article-title: Glycogen phosphorylase inhibitors: a patent review (2013 - 2015)
  publication-title: Expert Opin Ther Pat.
  doi: 10.1517/13543776.2016.1131268
  contributor:
    fullname: Donnier-Marechal
– volume: 79
  start-page: 1019
  year: 2019
  ident: B14
  article-title: AKT as a therapeutic target for cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-2738
  contributor:
    fullname: Song
– volume: 73
  start-page: 349
  year: 2014
  ident: B100
  article-title: Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose
  publication-title: Cancer Chemother Pharmacol.
  doi: 10.1007/s00280-013-2358-8
  contributor:
    fullname: Philips
– volume: 27
  start-page: 416
  year: 2017
  ident: B88
  article-title: Novel method for detection of glycogen in cells
  publication-title: Glycobiology.
  doi: 10.1093/glycob/cwx005
  contributor:
    fullname: Skurat
– volume: 8
  start-page: e64570
  year: 2013
  ident: B94
  article-title: Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0064570
  contributor:
    fullname: Yoshii
– volume: 21
  start-page: 94
  year: 2019
  ident: B47
  article-title: The dynamic nature of senescence in cancer
  publication-title: Nat Cell Biol.
  doi: 10.1038/s41556-018-0249-2
  contributor:
    fullname: Lee
– volume: 10
  start-page: 4270s
  year: 2004
  ident: B125
  article-title: Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-040020
  contributor:
    fullname: Shapiro
– volume: 26
  start-page: 558
  year: 2017
  ident: B57
  article-title: Cell-intrinsic glycogen metabolism supports early glycolytic reprogramming required for dendritic cell immune responses
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2017.08.012
  contributor:
    fullname: Thwe
– volume: 71
  start-page: 523
  year: 2013
  ident: B102
  article-title: A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
  publication-title: Cancer Chemother Pharmacol.
  doi: 10.1007/s00280-012-2045-1
  contributor:
    fullname: Raez
– volume: 106
  start-page: dju062
  year: 2014
  ident: B119
  article-title: Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease
  publication-title: J Natl Cancer Inst.
  doi: 10.1093/jnci/dju062
  contributor:
    fullname: Guin
– volume: 113
  start-page: E4966
  year: 2016
  ident: B131
  article-title: Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
  publication-title: Proc Natl Acad Sci U S A.
  doi: 10.1073/pnas.1603244113
  contributor:
    fullname: Yang
– volume: 35
  start-page: 798
  year: 2019
  ident: B116
  article-title: Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the PP2A-GSK3beta-MCL-1 axis
  publication-title: Cancer cell.
  doi: 10.1016/j.ccell.2019.03.007
  contributor:
    fullname: Elgendy
– volume: 74
  start-page: 1319
  year: 2014
  ident: B92
  article-title: A novel radiotracer to image glycogen metabolism in tumors by positron emission tomography
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-13-2768
  contributor:
    fullname: Witney
– volume: 23
  start-page: 1891
  year: 2017
  ident: B113
  article-title: Molecular pathways: revisiting glycogen synthase kinase-3β as a target for the treatment of cancer
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-2240
  contributor:
    fullname: Walz
– volume: 4
  start-page: 70
  year: 2018
  ident: B46
  article-title: Senescence and cancer
  publication-title: Cancer Transl Med.
  doi: 10.4103/ctm.ctm_22_18
  contributor:
    fullname: Zeng
– volume: 20
  start-page: 74
  year: 2020
  ident: B13
  article-title: The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
  publication-title: Nat Rev Cancer.
  doi: 10.1038/s41568-019-0216-7
  contributor:
    fullname: Hoxhaj
– volume: 9
  start-page: 322
  year: 2019
  ident: B62
  article-title: A metabolism toolbox for CAR T therapy
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2019.00322
  contributor:
    fullname: Xu
– volume: 458
  start-page: 53
  year: 2018
  ident: B91
  article-title: Analysis of glycogen metabolic pathway utilization by dendritic cells and T cells using custom phenotype metabolic assays
  publication-title: J Immunol Methods.
  doi: 10.1016/j.jim.2018.04.006
  contributor:
    fullname: Thwe
– volume: 12
  start-page: 1547
  year: 2014
  ident: B101
  article-title: Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion
  publication-title: Mol Cancer Res.
  doi: 10.1158/1541-7786.MCR-14-0106-T
  contributor:
    fullname: Abbadi
– volume: 499
  start-page: 43
  year: 2013
  ident: B43
  article-title: Comprehensive molecular characterization of clear cell renal cell carcinoma
  publication-title: Nature.
  doi: 10.1038/nature12222
  contributor:
    fullname: Creighton
– volume: 293
  start-page: 7089
  year: 2018
  ident: B2
  article-title: The dynamic life of the glycogen granule
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.R117.802843
  contributor:
    fullname: Prats
– volume: 27
  start-page: e31
  year: 2016
  ident: B83
  article-title: Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
  publication-title: J Gynecol Oncol.
  doi: 10.3802/jgo.2016.27.e31
  contributor:
    fullname: Mabuchi
– volume: 28
  start-page: 914
  year: 2017
  ident: B109
  article-title: PI3K/AKT inhibitors in patients with refractory renal cell carcinoma: what have we learnt so far?
  publication-title: Ann Oncol.
  doi: 10.1093/annonc/mdx104
  contributor:
    fullname: Vlachostergios
– volume: 2017
  start-page: 4629495
  year: 2017
  ident: B86
  article-title: Multifaceted roles of GSK-3 in cancer and autophagy-related diseases
  publication-title: Oxid Med Cell Longev.
  doi: 10.1155/2017/4629495
  contributor:
    fullname: Mancinelli
– volume: 29
  start-page: 1741
  year: 2010
  ident: B105
  article-title: Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes
  publication-title: Oncogene.
  doi: 10.1038/onc.2009.470
  contributor:
    fullname: Yamaguchi
– volume: 70
  start-page: 591
  year: 2020
  ident: B28
  article-title: Pathology of clear cell carcinoma of the ovary: a basic view based on cultured cells and modern view from comprehensive approaches
  publication-title: Pathol Int.
  doi: 10.1111/pin.12954
  contributor:
    fullname: Kato
– volume: 309
  start-page: 126
  year: 2003
  ident: B127
  article-title: Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression
  publication-title: Biochem Biophys Res Commun.
  doi: 10.1016/S0006-291X(03)01542-0
  contributor:
    fullname: Schnier
– volume: 24
  start-page: 1161
  year: 2017
  ident: B70
  article-title: Targeting metabolism for cancer therapy
  publication-title: Cell Chem Biol.
  doi: 10.1016/j.chembiol.2017.08.028
  contributor:
    fullname: Luengo
– volume: 7
  start-page: 22650
  year: 2016
  ident: B41
  article-title: Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.7998
  contributor:
    fullname: Gomez-Roman
– volume: 91
  start-page: 2094
  year: 2004
  ident: B122
  article-title: Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment
  publication-title: Br J Cancer.
  doi: 10.1038/sj.bjc.6602243
  contributor:
    fullname: Lee
– volume: 181
  start-page: 424
  year: 2020
  ident: B50
  article-title: Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer
  publication-title: Cell.
  doi: 10.1016/j.cell.2020.03.008
  contributor:
    fullname: Ruscetti
– volume: 589
  start-page: 3383
  year: 2011
  ident: B78
  article-title: Brain glycogen decreases during prolonged exercise
  publication-title: J Physiol.
  doi: 10.1113/jphysiol.2011.203570
  contributor:
    fullname: Matsui
– volume: 20
  start-page: 21
  year: 2018
  ident: B60
  article-title: A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells
  publication-title: Nat Cell Biol.
  doi: 10.1038/s41556-017-0002-2
  contributor:
    fullname: Ma
– volume: 575
  start-page: 380
  year: 2019
  ident: B95
  article-title: In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
  publication-title: Nature.
  doi: 10.1038/s41586-019-1715-0
  contributor:
    fullname: Momcilovic
– volume: 18
  start-page: 343
  year: 2018
  ident: B35
  article-title: Role of HIF-1 in cancer progression: novel insights. A review
  publication-title: Curr Mol Med.
  doi: 10.2174/1566524018666181109121849
  contributor:
    fullname: Pezzuto
– volume: 11
  start-page: 1769
  year: 2020
  ident: B59
  article-title: Glycogen metabolism regulates macrophage-mediated acute inflammatory responses
  publication-title: Nat Commun.
  doi: 10.1038/s41467-020-15636-8
  contributor:
    fullname: Ma
– volume: 35
  start-page: 5556
  year: 2017
  ident: B115
  article-title: A phase II clinical trial of metformin as a cancer stem cell targeting agent in stage IIc/III/IV ovarian, fallopian tube, and primary peritoneal cancer
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.2017.35.15_suppl.5556
  contributor:
    fullname: Buckanovich
– volume: 15
  start-page: 683
  year: 2018
  ident: B114
  article-title: Metformin and cancer: an existing drug for cancer prevention and therapy
  publication-title: Oncol Lett.
  doi: 10.3892/ol.2017.7412
  contributor:
    fullname: Zi
– volume: 16
  start-page: 751
  year: 2012
  ident: B12
  article-title: Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2012.10.017
  contributor:
    fullname: Favaro
– volume: 30
  start-page: 903
  year: 2019
  ident: B51
  article-title: Nuclear glycogenolysis modulates histone acetylation in human non-small cell lung cancers
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2019.08.014
  contributor:
    fullname: Sun
– volume: 8
  start-page: 237
  year: 2018
  ident: B61
  article-title: Targeting T cell metabolism for improvement of cancer immunotherapy
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2018.00237
  contributor:
    fullname: Le Bourgeois
– volume: 45
  start-page: 405
  year: 2015
  ident: B80
  article-title: Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy
  publication-title: Jpn J Clin Oncol.
  doi: 10.1093/jjco/hyu221
  contributor:
    fullname: Yamashita
– volume: 4
  start-page: 9040
  year: 2019
  ident: B103
  article-title: Recent advance of Akt inhibitors in clinical trials
  publication-title: ChemistrySelect.
  doi: 10.1002/slct.201901293
  contributor:
    fullname: Guo
– volume: 25
  start-page: 821
  year: 2018
  ident: B130
  article-title: RIP3 is an upregulator of aerobic metabolism and the enhanced respiration by necrosomal RIP3 feeds back on necrosome to promote necroptosis
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-018-0075-x
  contributor:
    fullname: Qiu
– volume: 12
  start-page: 383
  year: 2015
  ident: B21
  article-title: Targeting glycogen metabolism in bladder cancer
  publication-title: Nat Rev Urol.
  doi: 10.1038/nrurol.2015.111
  contributor:
    fullname: Ritterson Lew
– volume: 219
  start-page: e202001006
  year: 2020
  ident: B30
  article-title: The stress-responsive gene GDPGP1/mcp-1 regulates neuronal glycogen metabolism and survival
  publication-title: J Cell Biol.
  doi: 10.1083/jcb.201807127
  contributor:
    fullname: Schulz
– volume: 120
  start-page: 109449
  year: 2019
  ident: B16
  article-title: Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p
  publication-title: Biomed Pharmacother.
  doi: 10.1016/j.biopha.2019.109449
  contributor:
    fullname: Zhou
– volume: 50
  start-page: 203
  year: 2019
  ident: B38
  article-title: Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
  publication-title: EBioMedicine.
  doi: 10.1016/j.ebiom.2019.11.017
  contributor:
    fullname: Tan
– volume: 24
  start-page: 653
  year: 2016
  ident: B64
  article-title: Macrophage metabolism shapes angiogenesis in tumors
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2016.10.016
  contributor:
    fullname: Mantovani
– volume: 41
  start-page: 397
  year: 2012
  ident: B123
  article-title: Inhibition of glycogen phosphorylation induces changes in cellular proteome and signaling pathways in MIA pancreatic cancer cells
  publication-title: Pancreas.
  doi: 10.1097/MPA.0b013e318236f022
  contributor:
    fullname: Ma
– volume: 275
  start-page: 374
  year: 2014
  ident: B31
  article-title: The role of glycogen, glucose and lactate in neuronal activity during hypoxia in the hooded seal (Cystophora cristata) brain
  publication-title: Neuroscience.
  doi: 10.1016/j.neuroscience.2014.06.024
  contributor:
    fullname: Czech-Damal
– volume: 529
  start-page: 298
  year: 2016
  ident: B69
  article-title: Metastatic colonization by circulating tumour cells
  publication-title: Nature.
  doi: 10.1038/nature17038
  contributor:
    fullname: Massagué
– volume: 4
  start-page: 62
  year: 2019
  ident: B52
  article-title: Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
  publication-title: Signal Transduct Target Therapy.
  doi: 10.1038/s41392-019-0095-0
  contributor:
    fullname: Cheng
SSID ssj0000650103
Score 2.4241045
SecondaryResourceType review_article
Snippet Once thought to be exclusively a storage hub for glucose, glycogen is now known to be essential in a range of physiological processes and pathological...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 592455
SubjectTerms cancer metabolism
cancer therapy
chemoresistance
glycogen
immunometabolism
metabolic reprogramming
Oncology
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iQbyIT1xfRPDiodqmTZp4Wxd1EdaDrOAtNGmiC5LKsh78986ku9KevHjpoQ00_SbpfB-ZByEXJs1NLa1MhIAVXDifJYbBpZBZKovKZt5gvvPkSYxfisdX_tpp9YUxYW154Ba4a-4cuGBbGnBshVe8EkDQmWeyTi2Qm7Z6aco6Yqr9B3NsYNCeS4IKU9e-CVixkKVXHCQHZvZ1_FAs19_jmP0IyY7Lud8mW0uuSIftHHfImgu7ZGOyPA3fI_o5poZj4DJ9-Pi2DSwGOgt0hJac39AhxXacnzP7BfKeVqGm0xj3jdlS9C4mTc1p4-kEuPgbBsTQaYfGNmGfvNzfTUfjZNkwIbHAKxaJy2DClRDGeVfzzCvpWVXDNlXOZmntge4oa1ED5sIy7nIjCuGVT53F81eVH5D10AR3SGhegpQCELk1IAFzp7gU0svYvyqrlBuQyxV8-rOti6FBTyDUGqHWCLVuoR6QW8T3dxxWtI43wM56aWf9l50H5HxlHQ07AI81quAAPs0KIE0wgrEBKXtm672x_yTM3mMt7VKAYsrKo_-Y4jHZxK-Oni09IeuL-Zc7BcqyMGdxdf4AmpnqHg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS-QwGA67LgxeFtcPdtbdJcJePFTbtEnTBVlccRyE2YPMgLfQpIkODKnWEfTf-75px52CJy89tEk_niR9n4e8H4T80nGqK2lkJATM4My6JNIMDplMYpmVJnEa450n_8R4ll1e8-v_4dEdgA9vSjusJzVrFkdP989_YMGfoOIEe3vsao_JCFl8xEFNcP6RfGJgF9HBa9KR_fa_zLGoQbtX-WbHTTJIYYJnwcFuzUyFbP49Ctp3oFyzSKMt8rmjkvS0Hfsv5IP122Qw6TbLd4i6CpHj6NdMLxbPpoa5QueenuFAN7_pKcVqnXdz8wjqn5a-otPgFo7BVPQ8xFQ1tHZ0AlT9Bv1l6HSN5dZ-l8xG59OzcdTVU4gM0I5lZBN44VIIbZ2teOIK6VhZwSourEniygEbKoxBiZgKw7hNtciEK1xsDW7PFuke2fC1t18JTXNQWoAnNxoUYmoLLoV0MpS3SsrCDsnhCj5116bNUCA3EHWFqCtEXbWoD8lfxPe1HSa8Difq5kZ160dxa4GJmVwDv8lcwUsBOo05JqvYAMeFmxysRkfBAsFdj9JbgE-xDDgVtGBsSPLesPWe2L_i57ch1XYuQFAl-bd399wnm_ipwdrF38nGsnm0P4DGLPXPMDtfALFx80o
  priority: 102
  providerName: Scholars Portal
Title Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation
URI https://search.proquest.com/docview/2463599522
https://pubmed.ncbi.nlm.nih.gov/PMC7667517
https://doaj.org/article/5ee251c7b0914f95a69662f28d0c9995
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBa7eyi9lD5p-lhU6KUHJ5YsyVJv27APCi6lZCE3YcnSNrArh5A99N93RnZKfO1FB1u25Zmx9X3Mi5DPrqxcp70ulAILFiGywnEYhGalFq1n0WG-c_ND3dyK72u5PiHykAuTg_a928zT_cM8bX7n2Mrtg18c4sQWP5tlrQDmsnpxSk5h-z2i6MPvV2LvgsElCQTMLGKfsFghL-cS2IbEZjUV2LHIcXRHu1Eu2j9BmtM4yaON5-o5eTYiRnoxrOwFOQnpJXnSjD7xV8T-ygniGL5Mr-__-B5Mgm4SXaI-d1_pBcWmnNuNfwSST9vU0VWO_sacKXqZU6d2tI-0AUR-h2ExdHUEZvv0mtxeXa6WN8XYNqHwgC72RWCw4FYpF2LoJItGR9528LGa4FnZRQA9xntkgpXyXIbKKaGiiWXw6IU11RtylvoU3hJa1UCoQJ7SOyCCVTBSKx117mLFWhNm5MtBfHY7VMewwCpQ6halblHqdpD6jHxD-f6bh3Wt84F-d2dH7VoZAgAuXzuAMSIa2SqgYzxy3ZUeoCzc5NNBOxa-A3RutCmA-CwXAJ1gBuczUk_UNnni9AwYWK6oPRrUu_--8j15iq-aN7XyAznb7x7DR0Are3eeWT6M12sGYyP0ebbXv2Mj7kc
link.rule.ids 230,314,727,780,784,864,885,2102,24318,27924,27925,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4qlueRmJC4fsxk7s2NzKqmWBpkJoK_VmxY5dVmqd1Wp76L9nxsmizZVLDomTODPj-Ps0L0I-2bywrXIqkxIsuPSBZZbDoVQsV2XjWLCY71xfyMVl-eNKXB0QscuFSUH7zq6m8eZ2Gld_Umzl-tbNdnFis1_1vJIAc1k1e0AeiqLSbI-k9z9ggd0LeqckUDA9C13EcoU8nwrgGwLb1RRgyWWKpNvbj1LZ_hHWHEdK7m09Z8_I0wEz0pN-bs_JgY8vyKN68Iq_JOZ3ShHHAGb67ebedWAUdBXpHDW6-UJPKLblXK_cHdB82sSWLlP8N2ZN0dOUPLWhXaA1YPJrDIyhyz0428VX5PLsdDlfZEPjhMwBvthmnsGEGymtD74VLGgVeNPCctXesbwNAHu0c8gFC-m48IWVpQw65N6hH1YXr8lh7KI_IrSogFKBPIWzQAULr4WSKqjUx4o12k_I5534zLqvj2GAV6DUDUrdoNRNL_UJ-Yry_TcOK1unE93m2gz6NcJ7gFyusgBkyqBFI4GQ8cBVmzsAs_CQjzvtGFgJ6N5oogfxGV4CeIIRnE9INVLb6I3jK2Biqab2YFLH_33nB_J4sazPzfn3i59vyBP87LTF5W_J4XZz598Bdtna98lS_wJHmu7c
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUXRHmIhRaMxIVDNokTOza3dtulPLaq0FbqzYodu12pdVar7YF_3xkni5IrlxwSJ3FmxvH3aV6EfDFZYRppZSIEWHDpfJ4YBodS5pksa5t7g_nOiwtxflX-vObXg1ZfMWjfmtU03N1Pw-o2xlau7226ixNLLxezSgDMzat03fj0KXnGCzCyAVHvfsIcOxh0jkmgYSr1bcCShSybcuAcHFvWFGDNZYymG-xJsXT_CG-OoyUH28_8JXnR40Z63M3vgDxx4RXZX_Se8ddE_4lp4hjETL_f_bUtGAZdBTpDrW6-0WOKrTnXK_sAVJ_WoaHLGAOOmVP0LCZQbWjr6QJw-Q0Gx9DlANK24Q25mp8tZ-dJ3zwhsYAxtonLYcK1EMZ51_DcK-lZ3cCSVc7mWeMB-ihrkQ8WwjLuCiNK4ZXPnEVfrCrekr3QBveO0KICWgXy5NYAHSyc4lJIL2Mvq7xWbkK-7sSn112NDA3cAqWuUeoapa47qU_ICcr33zisbh1PtJsb3etYc-cAdtnKAJgpveK1AFLGPJNNZgHQwkM-77SjYTWgi6MODsSnWQkACkYwNiHVSG2jN46vgJnFutq9Wb3_7zs_kf3L07n-_ePi1wfyHL867nLZIdnbbh7cEcCXrfkYDfURt_3v7w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revisiting+Glycogen+in+Cancer%3A+A+Conspicuous+and+Targetable+Enabler+of+Malignant+Transformation&rft.jtitle=Frontiers+in+oncology&rft.au=Khan%2C+Tashbib&rft.au=Sullivan%2C+Mitchell+A.&rft.au=Gunter%2C+Jennifer+H.&rft.au=Kryza%2C+Thomas&rft.date=2020-10-30&rft.pub=Frontiers+Media+S.A&rft.eissn=2234-943X&rft.volume=10&rft_id=info:doi/10.3389%2Ffonc.2020.592455&rft_id=info%3Apmid%2F33224887&rft.externalDBID=PMC7667517
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon